Advances in Parkinson's Disease
Vol.6 No.1(2017), Paper ID 73986, 10
pages
DOI:10.4236/apd.2017.61002
Levodopa/Carbidopa Intestinal Gel for Treatment of Advanced Parkinson’s Disease: An Update on the Effects of Cognitive Functions
Pamela Latino, Stefania Tagliente, Clelia Pellicano, Morena Giovannelli, Francesco E. Pontieri
Department of Neuroscience, Mental Health and Sensory Organs (NeSMOS), “Sapienza” University, Rome, Italy
Department of Neuroscience, Mental Health and Sensory Organs (NeSMOS), “Sapienza” University, Rome, Italy
Department of Neuroscience, Mental Health and Sensory Organs (NeSMOS), “Sapienza” University, Rome, Italy
Unit of Neurology, Sant’Andrea Hospital, Rome, Italy
Department of Neuroscience, Mental Health and Sensory Organs (NeSMOS), “Sapienza” University, Rome, Italy
Department of Clinical and Behavioral Neurology, “Santa Lucia Foundation” IRCCS, Rome, Italy
Copyright © 2017 Pamela Latino, Stefania Tagliente, Clelia Pellicano, Morena Giovannelli, Francesco E. Pontieri et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Latino, P. , Tagliente, S. , Pellicano, C. , Giovannelli, M. and Pontieri, F. (2017) Levodopa/Carbidopa Intestinal Gel for Treatment of Advanced Parkinson’s Disease: An Update on the Effects of Cognitive Functions.
Advances in Parkinson's Disease,
6, 13-23. doi:
10.4236/apd.2017.61002.